However, although 2-phenyl-4-quinolone derivatives have previously been shown to confer strong anti-tumor activity [32,36,51], whether these CMQ and FMQ phytocompound-derived chemicals could induce maturation of DCs and subsequently enhance CD4+ T and CD8+ T cell activities has not been reported. The gene discussed is CD8A; the disease is neoplasm.